Current Opinion in Gastroenterology

 
 

  • Diet and Carcinogenesis of Gastric Cancer What dietary factors offer protection against gastric cancer--and which foods increase the risk? This review summarizes the current body of evidence on the association of diet with gastric cancer.
  • Medical Malpractice and Gastrointestinal Endoscopy This paper explores malpractice as it relates to gastroenterologists, including historical trends and specific vulnerabilities. How can the gastroenterologist best manage risk while delivering care?
  • Management of Refractory Eosinophilic Esophagitis Refractory eosinophilic esophagitis remains challenging to treat. Review reasons for non-response to therapy and options for these patients in this paper.
  • Endohepatology - Current Status Learn about new advances in the emerging field of endohepatology, the use of diagnostic and therapeutic endoscopic tools for the management of patients with liver disease and portal hypertension.
  • Should High-fiber Diets Be Recommended for Patients With IBD? Patients with IBD are often intolerant of dietary fiber and have been counseled to avoid it, but emerging evidence suggests that increased dietary fiber intake may be both tolerable and beneficial.
  • Hemorrhoids, Skin Tags and All Things Perianal Review recent advances in management of common benign anorectal diseases including hemorrhoids, anal fissure, and anal fistula.
  • Advances in the Treatment of Gastric Cancer: 2020-2021 This review presents an update of recent advances in the treatment of esophageal and gastric cancers, including the use of immune checkpoint inhibitor therapy as first-line treatment.
  • Single-use Duodenoscopes: Where Are We and Where Are We Going? How feasible are single-use disposable duodenoscopes? This commentary reviews the current status and future prospects of this new technology.
  • Diagnosis and Management of C. Difficile in Patients With IBD Clostridioides difficile infection is a common but serious complication of IBD, and can present atypically. Review the risk factors, diagnosis, and management of CDI in IBD patients in this article.
  • Novel Treatments for Alcoholic Hepatitis This review summarizes several promising therapeutic options under clinical investigation for the treatment of alcoholic hepatitis and alcohol-associated liver disease.
  • Dietary Interventions and IBS: What Really Works? Diet can be both a trigger of IBS symptoms as well as a therapeutic tool. What does the latest research reveal regarding the use of dietary interventions in the management of IBS?
  • COVID-19: Implications for the Gastroenterologist Review the gastrointestinal symptoms that may present in patients with COVID-19 as well as the impact of COVID-19 in patients with chronic gastrointestinal diseases.
  • Advances in the Treatment of Gastric Cancer This article provides an updated review on the surgical and adjuvant management of cancers of the stomach and esophagogastric junction.
  • Early Detection of Pancreatic Cancer Detecting pancreatic cancer at its earliest stages remains challenging. What recent progress has been made in this area?
  • Opioid-induced Esophageal Dysfunction Opioid-induced esophageal dysfunction is common in chronic opioid users. Review its pathophysiology, diagnosis, and management in this article.
  • Refractory Celiac Disease: What Should We Be Doing Different? This article examines the challenges of accurately diagnosing and managing patients with celiac disease who do not demonstrate clinical improvement with a gluten-free diet.
  • Cancer Cachexia: A Multifactoral Disease Cancer cachexia is a complex condition with multifactorial etiologies, which should optimally be managed by a multidisciplinary team that includes an oncologist, pharmacist, and oncology dietitian.
  • Immune-checkpoint Inhibitors Induced Diarrhea and Colitis Might immune-checkpoint inhibitor induced diarrhea and colitis represent more than just an adverse reaction? New evidence suggests these events might aid in assessment of response to ICI therapy.
  • PPIs: Placing Putative Adverse Effects in Proper Perspective Are doctors modifying PPI therapy based on solid scientific evidence? Most serious adverse effects attributed to PPIs are based on observational data.
  • Chronic Pancreatitis The authors review important new observations that relate to pathogenesis and prevalence, improving diagnosis, alleviating suffering and decreasing the cost of chronic pancreatitis.